CLINICAL TRIALS PROFILE FOR GRANISETRON HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for GRANISETRON HYDROCHLORIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00003213 ↗ | Drugs to Reduce the Side Effects of Chemotherapy | Completed | Swiss Group for Clinical Cancer Research | Phase 3 | 1996-05-01 | RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients treated with chemotherapy. It is not known whether receiving dexamethasone with granisetron is more effective than receiving dexamethasone with metoclopramide for reducing the side effects of chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of dexamethasone with either granisetron or metoclopramide in patients treated with chemotherapy. |
| NCT00004219 ↗ | Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma | Unknown status | Simbec Research | Phase 3 | 1969-12-31 | RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients treated with radiation therapy. It is not yet known whether lerisetron is more effective than granisetron in preventing nausea and vomiting. PURPOSE: Randomized phase III trial to compare the effectiveness of lerisetron with that of granisetron in preventing nausea and vomiting in men who are being treated with radiation therapy for stage I seminoma. |
| NCT00005024 ↗ | Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease | Unknown status | National Cancer Institute (NCI) | Phase 3 | 1969-12-31 | RATIONALE: Antiemetic drugs such as granisetron may help to prevent nausea and vomiting in patients treated with chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of granisetron with that of a placebo in preventing nausea and vomiting after chemotherapy in patients who have malignant disease. |
| NCT00005024 ↗ | Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease | Unknown status | Jonsson Comprehensive Cancer Center | Phase 3 | 1969-12-31 | RATIONALE: Antiemetic drugs such as granisetron may help to prevent nausea and vomiting in patients treated with chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of granisetron with that of a placebo in preventing nausea and vomiting after chemotherapy in patients who have malignant disease. |
| NCT00020657 ↗ | Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer | Completed | National Cancer Institute (NCI) | Phase 3 | 2001-07-01 | RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients being treated with chemotherapy. PURPOSE: This randomized phase III trial is comparing how well different antiemetic drugs work in preventing delayed nausea after chemotherapy in patients who have cancer. |
| NCT00020657 ↗ | Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer | Completed | Gary Morrow | Phase 3 | 2001-07-01 | RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients being treated with chemotherapy. PURPOSE: This randomized phase III trial is comparing how well different antiemetic drugs work in preventing delayed nausea after chemotherapy in patients who have cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for GRANISETRON HYDROCHLORIDE
Condition Name
Clinical Trial Locations for GRANISETRON HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for GRANISETRON HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for GRANISETRON HYDROCHLORIDE
Sponsor Name
